Abstract:Abstract Cyclin-dependent protein kinases (CDKs) regulate the eukaryotic cell cycle progression. Dysregulated cell cycle leading to unscheduled cell proliferation is a characteristic of many cancer subtypes. Since some tumor cells require specific interphase CDKs for proliferation, understanding CDKs activation mechanisms and their differential recognition of cognate cyclins and substrate proteins are essential for developing selective CDK inhibitors for cancer treatments. To date, while the crystal structure of the active CDK2 in complex with cyclin-E is available, no crystal structure for active CDK4 with its cognate cyclin-D is resolved. Here, we model the CDK4/cyclin-D complex as well as CDK2 in complex with cyclin-E to study the conformational dynamics and activation processes of G1 and G1/S phases CDKs, respectively. Extensive molecular dynamics (MD) simulations were performed for both CDK complexes with the kinases in different transition states to resolve the differences in their allosteric regulations at the atomic level. We illustrate that the inactive CDK4 in complex with cyclin-D is in the intermediate state on its pathway to activation in contrast to the fully active CDK2 in complex with cyclin-E, suggesting its activation mechanism is distinct from that of CDK2. This suggests that additional steps such as ATP binding, extension of the activation loop (A-loop), rotation of αC-helix towards “IN” conformation, phosphorylation of A-loop, and substrate binding are required for CDK4. CDK2 interacts with cyclin-E through a large interfacial area (or interface) that stabilizes the protein-protein interaction, while CDK4 has a smaller interfacial area (or interface) in the interaction with cyclin-D. Our simulations affirm experimental data on the current understanding of activation mechanisms of CDK2 and CDK4 and reveal additional atomistical characteristics of their dynamics and activations. Our works report the complete activation mechanisms of CDK2/4, providing insights into the inhibition of these complexes at an atomic level, and are useful for identifying potential targets for drug discovery in oncology. Citation Format: Wengang Zhang, Yonglan Liu, Mingzhen Zhang, Hyunbum Jang, Ruth Nussinov. Deciphering the activation mechanism of CDK4/cyclin-D complex that differs from the CDK2/cyclin-E complex [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 872.

Binding Modalities and Phase-Specific Regulation of Cyclin/Cyclin-Dependent Kinase Complexes in the Cell Cycle

Cell Cycle Progression Mechanisms: Slower Cyclin-D/cdk4 Activation and Faster Cyclin-E/cdk2.

Slower CDK4 and faster CDK2 activation in the cell cycle

CDK2 and CDK4: Cell Cycle Functions Evolve Distinct, Catalysis-Competent Conformations, Offering Drug Targets

Core control principles of the eukaryotic cell cycle

Abstract 872: Deciphering the Activation Mechanism of CDK4/cyclin-D Complex That Differs from the CDK2/cyclin-E Complex

Advances in the studies of cyclin dependent kinase-activating kinase (CAK)

Cyclin dependent kinases and their role in regulation of plant cell cycle

High-throughput discovery and deep characterization of cyclin-CDK docking motifs

Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer.

Insights On Structural Characteristics And Ligand Binding Mechanisms Of Cdk2

Why minimal is not optimal: Driving the mammalian cell cycle—and drug discovery—with a physiologic CDK control network

Cyclin Dependent Kinase 1 Inhibitors: a Review of Recent Progress.

Structural studies with inhibitors of the cell cycle regulatory kinase cyclin-dependent protein kinase 2.

Cdks, cyclins and CKIs: roles beyond cell cycle regulation

CYCLINS AND CELL CYCLE CHECKPOINTS

The double dealing of cyclin D1

Structural insights into the functional diversity of the CDK–cyclin family

CDK Inhibitors: Cell Cycle Regulators and Beyond

Multisite Phosphorylation and Network Dynamics of Cyclin-Dependent Kinase Signaling in the Eukaryotic Cell Cycle.

Cyclin D- and E-Dependent Kinases and the P57(Kip2) Inhibitor: Cooperative Interactions in Vivo